News
Answers must be given. Because many, and various, are the questions. To report the importance of information and data ...
Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS treatment.
In your biological library, known as the brain, there are countless stories stored across billions of shelves. But with age, some sections start to collapse. No ...
Researchers still don’t fully understand the cause of multiple sclerosis or why the rate of progression is so difficult to ...
A new study published in Nature Metabolism suggests that intense endurance exercise, such as running a marathon, may cause a ...
Despite its growing role in tracking MS activity, serum neurofilament light chain lacks diagnostic specificity, experts say.
Fenebrutinib helped patients with relapsing forms of MS remain nearly free of relapses and disability progression up to two ...
Multiple sclerosis is an incurable condition that can occur at any point in life However it is most common in young adults – ...
The NHS has shared a tweet to raise awareness of multiple sclerosis (MS), an incurable condition that affects the central ...
While MS is still considered rare in India, we’re now seeing a shift toward moderate prevalence,” Dr M V Padma told Business Standard. “Currently, an estimated 150,000 to 200,000 people live with MS ...
Roche shares new data showing its MS drug fenebrutinib maintained low relapse rates and no disability progression in patients ...
The NHS has warned about potential symptoms of an incurable condition that profoundly affects the central nervous system. Although it can strike at any age, it is more commonly diagnosed in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results